Organigram Global (OGI) Cash from Discontinued Operations (2018 - 2026)
Organigram Global (OGI) posted quarterly Cash from Discontinued Operations of 16606201222.71 for Q1 2026, down 43.67% year-over-year from 29481592612.3 in Q1 2025, and down 144619174.12% quarter-over-quarter from 11482.7 in Q4 2025.
Organigram Global (OGI) Cash from Discontinued Operations (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Cash from Discontinued Operations for 7 consecutive years, with 16606201222.71 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Discontinued Operations fell 43.67% year-over-year to 16606201222.71; the TTM figure through Mar 2026 stood at 28164575453.97 (up 34.32% YoY), while the FY2021 annual figure was 5132000.0, changed N/A from the prior year.
- Cash from Discontinued Operations declined to 16606201222.71 in Q1 2026 per OGI's latest filing, from 11482.7 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 2992.25 in Q4 2024 and bottomed at 16606201222.71 in Q1 2026.
- Historically, Cash from Discontinued Operations has averaged 7041143863.49 across 3 years, with a median of 5779185619.5 in 2025.
- Annual changes were most pronounced in 2025 — Cash from Discontinued Operations slumped 283.75% — and 2026, when it sank 43.67%.
- Organigram Global's Cash from Discontinued Operations stood at 2992.25 in 2024, then plunged by 283.75% to 11482.7 in 2025, then tumbled by 144619174.12% to 16606201222.71 in 2026.
- Business Quant data shows OGI's Cash from Discontinued Operations at 16606201222.71 in Q1 2026, 11482.7 in Q4 2025, and 11558359756.31 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn | -16.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.61 Bn |
| Mar 31, 2026 | -16.61 Bn |
| Dec 31, 2025 | -11,482.70 |
| Dec 31, 2025 | -11,482.70 |
| Mar 31, 2025 | -11.56 Bn |
| Mar 31, 2025 | -11.56 Bn |
| Dec 31, 2024 | -2,992.25 |
| Dec 31, 2024 | -2,992.25 |
| May 31, 2021 | -20.89 Bn |
| May 31, 2021 | -20.89 Bn |
| Feb 28, 2021 | -10.43 Bn |
| Feb 28, 2021 | -10.43 Bn |
| Nov 30, 2020 | 294.00 Mn |
| Nov 30, 2020 | 294.00 Mn |
| May 31, 2020 | 313.00 |
| May 31, 2020 | 313.00 |
| Feb 29, 2020 | 25.01 Bn |
| Feb 29, 2020 | 25.01 Bn |
| Aug 31, 2019 | 15,722.00 |
| Aug 31, 2019 | 15,722.00 |